Picture EBD Group World of Partnering Opportunities 650x100px
Document › Details

SmartDyeLivery GmbH. (10/10/18). "Press Release: New Financing Round Secures further Development of Innovative Nanotherapies". Erfurt, München & Jena.

Organisations Organisation SmartDyeLivery GmbH
  Organisation 2 bm-t Beteiligungsmanagement Thüringen GmbH (bm|t)
  Group Thuringia (govt region)
Products Product nanoparticle technology
  Product 2 venture capital
Index terms Index term SmartDyeLivery–SEVERAL: investment, 201810 financing round from bm|t + business angel from Munich
  Index term 2 SmartDyeLivery–Thuringia (govt): investment, 201810 financing round from bm|t + business angel from Munich
Person Person Lehmann, Marc (SmartDyeLivery GmbH 20602 Managing Director)

A new private investor was convinced of the concept of the SmartDyeLivery GmbH from Jena, and the bm-t beteiligungsmanagement thüringen gmbh is expanding its investment.

SmartDyeLivery has successfully completed its latest financing round. With its innovative nanotechnology for medical applications, the young company from Jena was able to attract a business angel from Munich. bm-t beteiligungsmanagement thüringen gmbh also expanded its existing investment. "With the new growth capital, we are well positioned to reach the next stage in the development of our innovative therapy concept" says Dr. Marc Lehmann, CEO of SmartDyeLivery.

SmartDyeLivery develops functionalized nanoparticles that enclose active substances for targeted drug delivery directly into effected tissues or organs. The comprehensively patented system can be used for a broad range of applications in the field of therapy and enables a unique therapeutic approach due to its functionalisation. The SmartDyeLivery team is currently focusing on the therapy of septic liver failure with the aim of reducing the extremely high mortality rate of over 90%.

About the bm|t:

bm-t beteiligungsmanagement thüringen gmbh, based in Erfurt, is a subsidiary of the Thüringer Aufbaubank and the first address for investments in Thuringia. bm|t currently manages eight funds with a total invested volume of around €320 million, which invest in innovative companies in almost all sectors and in all phases of corporate development - both in the start-up and growth phases or in company succession situations. Further information about the bm|t can be found at sind verfügbar unter

About the SmartDyeLivery GmbH:

The SmartDyeLivery GmbH develops specific, nanoparticle-based transporters for therapeutic, diagnostic and theranostic applications. The aim is to provide new treatment options for previously untreatable or difficult to treat diseases in order to save lives. The underlying technologies are patent-protected and have been awarded a special prize in the context of the Thuringian Innovation Award. Further information can be found at


Dr. Marc Lehmann
Managing Director
SmartDyeLivery GmbH
Botzstraße 5
07743 Jena

Record changed: 2023-06-05


Picture Berlin Partner Voices Robinson Data for Precision Medicine 650x200px

More documents for SmartDyeLivery GmbH

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Picture Berlin Partner Top News Bayer Aignostics Collaboration 650x300px

» top